b'uCAREuCARE GOVERNANCELaurence Klotz,Mihir Desai,Ranan Dasgupta, Canada United States United KingdomChair, Office of Research Office of Research-Elect Research Committee ChairuCARE, SIUs Office of Research, is a platform for global clinicalresearch in urology. Through uCARE, urologists can access and be involved in SIU clinical studies and registries conducted worldwide. Through SIUs diverse membership and global partnerships, uCare becomes a global research consortium that enables us to:Connect urologist andShare knowledge and Provide access to a patients from the SIUsbuild our membersglobal network of group member countriesresearch capacity, allowingurological clinical to studies being conductedus to advance urologicaltrials and registriesaround the world research globallyCURRENT AND UPCOMING REGISTRY STUDIESGlobal Registry of Treatments and OutcomesGlobal Registry of Perioperative Systemic Therapy Selectionfor Benign Prostatic Hyperplasia and Treatment Outcomes for Bladder CancerBenign prostatic hyperplasia (BPH) is one of the mostBladder cancer is a common urological malignancy with over 573,000 newcommonly performed surgical procedures in urology.cases and almost 213,000 deaths estimated worldwide in 2020. Over the past Over the past few decades, there has been an increasing10 years, technological innovations in sequencing have led to rapid genomic development of new surgical treatment options.and transcriptomic characterization of bladder cancer, providing a moreAdditionally, the outcome parameters for BPH treatmentsin-depth understanding of its pathogenesis and leading to the development have been standardized. While data are available for theof new treatment approaches. To provide a better understanding of initial pivotal studies, post-market release data are lacking.the utilization of these treatment advances in the real-world clinical Under the umbrella of uCARE, the SIU has launchedpractice, the SIU is launching an international, prospective registry on a prospective, ongoing international registry to obtainperioperative treatment of bladder cancer. Under the umbrella of uCARE, demographics and outcome data from patients undergoingthis registry conducted in multiple SIU-affiliated centres across the globe surgical treatments for BPH. Please visit the uCAREwill obtain demographics and patient characteristics guiding the selection website (www.siu-urology.org/ucare/bph-registry-portal) forof perioperative therapy as well as treatment outcomes for bladder cancer information on how you can contribute to this initiative. treatment worldwide. Objectives ObjectivesTo analyze demographic patterns and baselineTo analyze demographic patterns and baseline characteristics of patients characteristics of patients undergoing surgicalguiding treatment decision-making for perioperative systemic therapytreatments for BPH in bladder cancerTo assess practice patterns (region-specific) for To assess practice patterns (region-specific) for perioperative systemic various surgical treatments for BPHtreatment of bladder cancer To assess key outcomes (efficacy and safety) forTo evaluate key outcomes (efficacy and safety) for perioperative systemic surgical treatments of BPH treatment of bladder cancerSpring 2023www.siu-urology.org 21'